← Leaderboards
Shailesh Agarwal
University Of Michigan At Ann Arbor
$985,996
Attributed
$985,996
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $214.4K · FY2015–25$250K$187.5K$125K$62.5K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$985,996 · 3
By mechanism
K08$518,280 · 1
R21$413,396 · 1
F32$54,320 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Chad M Brummett$8,965,950
- Richard E Harris$13,043,112
- Mark M Banaszak Holl$2,761,198
- Frankie Nicole Czesak$84,752
Others in their field
Top investigators on “Operative Surgical Procedures”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Larry Arthur$195,389,208
- Norman Wolmark · Nsabp Foundation, Inc.$177,775,854
- Lawrence Corey · Fred Hutchinson Cancer Center$130,508,383
- Richard K. Wilson · Washington University$128,382,063
Research focus
Operative Surgical ProceduresMouse ModelStem CellsOpen WoundPreventTissuesHindlimbTrainingAffectUnited StatesLymphaticLymphedemaSuccessImpairmentDepositionMonitorSkillsHistologicCancer PatientLaboratoriesLimb StructureLymphSwellingQuality Of Life
Grant awards (6)
Modifying adipocyte and pre-adipocyte cell fate in fibroadipose tissue of secondary lymphedema$172,760
K08 · FY2025 · AR · contact PI
Modifying adipocyte and pre-adipocyte cell fate in fibroadipose tissue of secondary lymphedema$172,760
K08 · FY2024 · AR · contact PI
Modifying adipocyte and pre-adipocyte cell fate in fibroadipose tissue of secondary lymphedema$172,760
K08 · FY2023 · AR · contact PI
Use of skin grafts programmed to express VEGF-C with biosensor feedback regulation to treat lymphedema$214,382
R21 · FY2021 · AR · contact PI
Use of skin grafts programmed to express VEGF-C with biosensor feedback regulation to treat lymphedema$199,014
R21 · FY2020 · AR · contact PI
Targeting Inflammation and BMP Signaling in Osteoprogenitor Cells of Heterotopic Ossification$54,320
F32 · FY2015 · AR · contact PI